Susquehanna International Group
SGTX

Susquehanna International Group’s Sigilon Therapeutics, Inc. Common Stock SGTX Stock Holding History

Susquehanna International Group’s Portfolio SGTX Stock Details SGTX Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Hold
2023
Q2 		– Sell
2023
Q1 		$133K Buy
2022
Q4 		$35K Sell
2022
Q3 		$58K Buy
2022
Q2 		$55K Buy
2022
Q1 		$27K Sell
2021
Q4 		$119K Buy
2021
Q3 		$137K Buy